Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial

Emma Guttman-Yassky*, Jonathan I. Silverberg, Diamant Thaçi, Kim A. Papp, Sonja Ständer, Lisa A. Beck, Brian S. Kim, Xiaofei Hu, Jianzhong Liu, Brian M. Calimlim, Namita Vigna, Jameson T. Crowley, Henrique D. Teixeira, Jacob P. Thyssen

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology